TWiV 520: This old mouse
The TWiVidae review universal influenza vaccines that are in clinical trials, and discovery of an atypical parvovirus that causes chronic kidney disease in middle aged, immunocompromised laboratory mice. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode PhD and postdoctoral programs at Dept of Microbiology, Icahn School of Medicine at Mount Sinai MSc program Molecular Biology and Pathology of Viruses, Univ College London Virology Comics on sale (Amazon) Ou...
Source: This Week in Virology - MP3 Edition - November 18, 2018 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
JAMA Internal Medicine : Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease
Interview with Nisha Bansal, MD, MAS, author of Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 5, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
CKD Screening Is Not for Everyone
Screening everyone for chronic kidney disease is neither cost-efficient nor useful, says Dr Berns. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - October 19, 2016 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
CKD In the elderly - disease, or disease label
Around half of people aged over 75 meet the diagnostic criteria for chronic kidney disease (CKD), but there is debate about what this means for patients as only a proportion of elderly people with CKD will have clinically important outcomes as a result.
In this podcast, Dr Arif Khwaja argues that for CKD in the elderly, we should focus on... (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 9, 2016 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
CKD In the elderly - disease, or disease label
Around half of people aged over 75 meet the diagnostic criteria for chronic kidney disease (CKD), but there is debate about what this means for patients as only a proportion of elderly people with CKD will have clinically important outcomes as a result.
In this podcast, Dr Arif Khwaja argues that for CKD in the elderly, we should focus on... (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 9, 2016 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts
CKD In the elderly - disease, or disease label
Around half of people aged over 75 meet the diagnostic criteria for chronic kidney disease (CKD), but there is debate about what this means for patients as only a proportion of elderly people with CKD will have clinically important outcomes as a result.
In this podcast, Dr Arif Khwaja argues that for CKD in the elderly, we should focus on patient centered outcomes rather than applying population risks.Read the full Analysis article: http://www.bmj.com/content/352/bmj.h6559 (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 9, 2016 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
CKD In the elderly - disease, or disease label
Around half of people aged over 75 meet the diagnostic criteria for chronic kidney disease (CKD), but there is debate about what this means for patients as only a proportion of elderly people with CKD will have clinically important outcomes as a result.
In this podcast, Dr Arif Khwaja argues that for CKD in the elderly, we should focus on patient centered outcomes rather than applying population risks.
Read the full Analysis article: http://www.bmj.com/content/352/bmj.h6559 (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 9, 2016 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
Anaemia is very common among patients with moderate or severe chronic kidney disease; and several treatments are available including iron supplementation, blood transfusions and synthetic derivatives of erythropoietin. In a Cochrane Review published in December 2014, Suetonia Palmer from Christchurch in New Zealand together with her colleagues, brought together the studies that have tested a range of erythropoietin drugs and she tells us what they found in this Evidence Pod. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - July 8, 2015 Category: Journals (General) Authors: Cochrane Source Type: podcasts
'We Can Do Better' With CKD and ESRD Patients
As he takes the reins as President of the National Kidney Foundation, Dr. Jeffrey Berns outlines ways to improve care in patients with chronic kidney disease and end-stage renal disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - August 29, 2014 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Lawrence Tim Goodnough, MD - Anemia in Chronic Kidney Disease: Practical Strategies to Optimize the Use of Iron Therapy
Anemia in Chronic Kidney Disease: Practical Strategies to Optimize the Use of Iron Therapy (Source: PeerView CME/CE Audio Podcast - Hematology)
Source: PeerView CME/CE Audio Podcast - Hematology - August 11, 2014 Category: Hematology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
In Advanced CKD, Thiazide May Help Control BP
Dr. George Bakris interviews Dr. Rajiv Agarwal about a small study that could redeem chlorthalidone ' s role in controlling blood pressure in patients with moderate to advanced chronic kidney disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - May 20, 2014 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
In Advanced CKD, Thiazide May Help Control BP
Dr. George Bakris interviews Dr. Rajiv Agarwal about a small study that could redeem chlorthalidone's role in controlling blood pressure in patients with moderate to advanced chronic kidney disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - May 20, 2014 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
The Future of Nephrology
'We need to be truly expert' in managing chronic kidney disease, says Dr. Jeffrey Berns, in order to preserve the specialty of nephrology. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - December 13, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
